Laden…
Synapedia is an independent knowledge project about psychoactive substances and harm reduction. If the platform helps you learn something new, you can support its development.
Every bit helps keep the project alive.
2-(2-oxopyrrolidin-1-yl)acetamide
Piracetam is a nootropic from the racetam class, primarily known for its cognitive-enhancing properties. It modulates glutamatergic AMPA receptors and influences neuronal membrane fluidity, which may lead to improved synaptic plasticity. Additionally, it supports acetylcholine release, which can positively affect memory performance. The substance is frequently studied in research for the treatment of cognitive impairments and is considered well-tolerated with a low risk profile.
Translation in progress
This section is currently being translated. Content will be available soon.
View German version →Receptor Targets
Mechanism of Action
Designations
IUPAC: 2-(2-ketopyrrolidino)acetamide
Legal Status
Legal status not verified by official sources. Please check current legislation independently.
Information without guarantee. Not legal advice.
Effects & Pharmacology — Translation in progress
This section is being translated. Content is available in German.
View in German →Total duration 6-8 hours
Peak
1-2 hours
Onset
30-60 minutes
Total duration
6-8 hours
After effects
2-4 hours
Start low. Individual sensitivity varies.
Dose sensitivity varies greatly between individuals. Body weight, tolerance, route of administration, and pre-existing conditions significantly affect outcomes.
Risks
Summary
Allgemein gut verträglich, jedoch können Nebenwirkungen auftreten.
Safer Use
The risks listed may be incomplete. Especially for research chemicals and rare substances, available data is limited.
May interact with other nootropics.
Possible interactions with anticoagulants.
Interaction data is based on known mechanisms. Unknown or rare interactions are possible and may be life-threatening.
Based on substance class, receptors, mechanisms, and effect profile.